Skip to main content

Solid Biosciences LLC (SLDB) Stock

Solid Biosciences LLC Stock Details, Movements and Public Alerts

Stock Details

Solid Biosciences LLC (SLDB), a prominent company in the healthcare sector within the biotechnology industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $7.31. Over the past 52 weeks, it has ranged between $2.41 and $8.20. This places the current price at 89.1% of its 52-week high and 203.3% above its 52-week low. Recent trading volume was recorded at 2,040,556. The 14-day Relative Strength Index (RSI) stands at 69.07, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $6.07 by 20.43%. Similarly, it is above its 200-day moving average of $5.54 by 31.95%. The MACD histogram is 0.13, indicating bullish momentum (MACD Line: 0.17, Signal Line: 0.04).

52-Week Range

$8.20 - $2.41

-10.85% from high · +203.32% from low

Avg Daily Volume

1,499,733

20-day average

100-day avg: 1,138,798

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Price to Book

2.41

EV/EBITDA

-3.69

EPS (TTM)

-$2.48

Price to Sales

3.65

Beta

2.76

More volatile than market

Q:How is SLDB valued relative to its earnings and growth?
Valuation data is not available for this stock.
Q:What is SLDB's risk profile compared to the market?
With a beta of 2.76, Solid Biosciences LLC is significantly more volatile than the market. For every 10% market move, this stock tends to move 28% in the same direction. Higher beta stocks offer greater potential returns but with increased risk. The price-to-book ratio of 2.41 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

0.00%

Operating Margin

0.00%

EBITDA

$-168,042,000

Return on Equity

-86.80%

Return on Assets

-43.70%

Revenue Growth (YoY)

-100.00%

Earnings Growth (YoY)

0.00%

Q:How profitable and efficient is SLDB's business model?
Profitability metrics are not available for this stock.
Q:What are SLDB's recent growth trends?
Solid Biosciences LLC's revenue declined by 100.00% year-over-year, indicating challenges in maintaining sales momentum. This contraction may reflect market headwinds, competitive pressures, or strategic transitions.0 These growth metrics should be evaluated against BIOTECHNOLOGY industry averages for proper context.

Company Size & Market

Market Cap

$525.9M

Revenue (TTM)

$0

Revenue/Share (TTM)

$0.00

Shares Outstanding

77.91M

Book Value/Share

$2.80

Asset Type

Common Stock

Q:What is SLDB's market capitalization and position?
Solid Biosciences LLC has a market capitalization of $525.9M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 77.91M shares outstanding, the company's ownership is relatively concentrated. As a participant in the BIOTECHNOLOGY industry, it competes with other firms in this sector.
Q:How does SLDB's price compare to its book value?
Solid Biosciences LLC's book value per share is $2.80, while the current stock price is $7.31, resulting in a price-to-book (P/B) ratio of 2.61. This reasonable premium to book value suggests the market values the company's earnings power and intangible assets appropriately. Most profitable companies trade between 1-3x book value. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$15.75

115.46% upside potential

Analyst Recommendations

Strong Buy

4

Buy

9

Hold

0

Sell

0

Strong Sell

0

Q:How reliable are analyst predictions for SLDB?
13 analysts cover SLDB with 100% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $15.75 implies 115.5% upside, but targets are often adjusted to follow price moves rather than predict them.
Q:What is the Wall Street consensus on SLDB?
Current analyst recommendations:4 Strong Buy, 9 Buy, 000The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Mar 10, 2026, 02:08 AM

Technical Indicators

RSI (14-day)

69.07

Neutral

50-Day Moving Average

$6.07

20.43% above MA-50

200-Day Moving Average

$5.54

31.95% above MA-200

MACD Line

0.17

MACD Signal

0.04

MACD Histogram

0.13

Bullish

Q:What does SLDB's RSI value tell investors?
The RSI (Relative Strength Index) for SLDB is currently 69.07, indicating the stock is showing bullish momentum (60-70 range). The stock has positive momentum without being extremely overbought. This zone often occurs during healthy uptrends where buyers remain in control. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
Q:How should traders interpret SLDB's MACD and moving average crossovers?
MACD analysis shows the MACD line at 0.17 above the signal line at 0.04, with histogram at 0.13. This bullish crossover suggests upward momentum is building. The 50-day MA ($6.07) is above the 200-day MA ($5.54), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently above both MAs, confirming strength.

Indicators last updated: Mar 10, 2026, 12:32 AM

Active Alerts

No active alerts for this stock.

Be the first to set up an alert for SLDB and get notified when the price changes.

Stay Ahead of the Market with Solid Biosciences LLC Alerts

Set up price alerts for Solid Biosciences LLC and get notified instantly when the price hits your target. Never miss an important price movement again.